CDC Announces Change In Recommendations For Use Of Antivirals;

CDC Announces Change In Recommendations For Use Of Antivirals;

ArticlePress release
Health & Wellness
Diseases & Conditions

CDC Announces Change in Recommendations for use of Antivirals;

Clinicians Should Not Prescribe Two Common Antivirals

Read the Transcript

The Centers for Disease Control and Prevention (CDC) announced today that clinicians should not prescribe two common antivirals (amantadine and rimantadine) to treat or prevent influenza during the 2005-2006 influenza season. Laboratory testing by CDC on the predominant strain of influenza (H3N2) currently circulating in the United States shows that it is resistant to these drugs.

CDC has tested 120 influenza A (H3N2) virus isolates and found that 109 (or 91 percent) were resistant to amantadine and rimantadine. This represents a sharp increase from last year when only 11 percent of isolates tested were resistant and 1.9 percent were resistant the year before that. However, all H3 and H1 influenza viruses tested to date are susceptible to the other commonly used antivirals (oseltamivir and zanamivir).

“This is certainly unexpected news as we now have to remove a few tools from our tool box that we use to combat influenza,” said CDC Director Dr. Julie Gerberding. “Thankfully we still have antivirals available that work but this new development serves as a reminder of the importance of getting people vaccinated to prevent them from getting influenza in the first place.”

During this period CDC recommends oseltamivir (Tamiflu) and zanamivir (Relenza) be prescribed if an antiviral medication is needed for the treatment or prevention of influenza.

Influenza activity is starting to pick up across the country as eighteen states are reporting either widespread or regional activity. Individuals who have not been vaccinated against influenza can still get vaccinated especially since influenza will continue to circulate for several more months. This year over 80 million doses of vaccine have been distributed but remaining supplies vary from state to state so individuals may have to check with more than one provider to receive vaccine. Also, CDC will have available 3.5 million doses from its stockpile to sell through manufacturers as soon as possible. In addition there are doses of vaccine presently available for sale by manufacturers and distributors.

Testing of influenza isolates for resistance to antivirals will continue throughout the 2005-2006 influenza season and recommendations will be updated as needed. In addition, CDC is working with state and local health departments and clinicians across the country to monitor drug resistance in influenza viruses.

For more information please visit www.cdc.gov/flu.

Department of Health and Human Services

Was this article helpful

On the Article

Subramanian Malaisamy MD, MRCP (UK), FCCP (USA) picture
Approved by

Subramanian Malaisamy MD, MRCP (UK), FCCP (USA)

Associate Chief Medical Officer, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!